Phylogica wins $1.5m deal

Perth-based drug discovery and biotechnology company Phylogica has signed a deal with major pharmaceutical operator AstraZeneca and its biologics unit MedImmune this week, a positive step for an industry that has had underwhelming investment and returns i


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer